1. Martinón-Torres F. Deciphering the burden of meningococcal disease: conventional and under-recognized elements. J Adolesc Health. 2016;59(2 Suppl):S12-20. https://doi.org/10.1016/j.jadohealth.2016.03.041.
2. Centers for Disease Control and Prevention (CDC). Revising the Adolescent Meningococcal Vaccine Schedule: Term of Reference and Considerations. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2024-02-28-29/02-Meningitis-Schillie-508.pdf. Accessed 8 Apr 2024.
3. Centers for Disease Control and Prevention (CDC). Meningococcal disease: Surveillance (Figure 2 data). https://www.cdc.gov/meningococcal/surveillance/index.html#trends. Accessed 12 Feb 2024.
4. Centers for Disease Control and Prevention (CDC). Enhanced meningococcal disease surveillance report. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2021.pdf. Accessed 12 Feb 2024.
5. Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application—a systematic and clinical review. BMC Public Health. 2022;22(1):1078. https://doi.org/10.1186/s12889-022-13342-2.